Search Results - Martin Fleisher
- Showing 1 - 20 results of 59
- Go to Next Page
-
1
Circulating Tumor Cells as Biomarkers in Prostate Cancer by Daniel C. Danila, Martin Fleisher, Howard I. Scher
Published 2011Revisão -
2
Circulating Tumors Cells as Biomarkers by Daniel C. Danila, Klaus Pantel, Martin Fleisher, Howard I. Scher
Published 2011Revisão -
3
-
4
-
5
Genotype/phenotype relationships in HNF-4alpha/MODY1: haploinsufficiency is associated with reduced apolipoprotein (AII), apolipoprotein (CIII), lipoprotein(a), and triglyceride le... by David Q. Shih, Hayes M. Dansky, Martin Fleisher, G. Aßmann, Stefan S. Fajans, Markus Stoffel
Published 2000Artigo -
6
-
7
-
8
-
9
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma by Richard J. Robbins, Shefali Srivastava, Ashok R. Shaha, Ronald Ghossein, Steven M. Larson, Martin Fleisher, R. Michael Tuttle
Published 2004Artigo -
10
-
11
-
12
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal by R. Michael Tuttle, Matvey Brokhin, Gal Omry, Andrew J. Martorella, Steven M. Larson, Ravinder K. Grewal, Martin Fleisher, Richard J. Robbins
Published 2008Artigo -
13
Correlation between estrogen receptor protein and carcinoembryonic antigen in normal and carcinomatous human breast tissue. by C Menendez-Botet, Jerome S. Nisselbaum, Martin Fleisher, Paul Peter Rosen, Alfred A. Fracchia, Guy F. Robbins, Jerome A. Urban, Morton K. Schwartz
Published 1976Artigo -
14
-
15
-
16
Clinical Validity of Detecting Circulating Tumor Cells by AdnaTest Assay Compared With Direct Detection of Tumor mRNA in Stabilized Whole Blood, as a Biomarker Predicting Overall S... by Daniel C. Danila, Aliaksandra Samoila, Chintan Patel, Nicole A. Schreiber, Amrita Herkal, Aseem Anand, Diogo Assed Bastos, Glenn Heller, Martin Fleisher, Howard I. Scher
Published 2016Artigo -
17
Analytic and Clinical Validation of a Prostate Cancer–Enhanced Messenger RNA Detection Assay in Whole Blood as a Prognostic Biomarker for Survival by Daniel C. Danila, Aseem Anand, Nikolaus Schultz, Glenn Heller, Mingliang Wan, Clifford C. Sung, Charles Dai, Raya Khanin, Martin Fleisher, Hans Lilja, Howard I. Scher
Published 2013Artigo -
18
Fluorescence <i>In situ</i> Hybridization Analysis of Circulating Tumor Cells in Metastatic Prostate Cancer by Margaret Leversha, Jialian Han, Zahra Asgari, Daniel C. Danila, Oscar Lin, Rita Gonzalez-Espinoza, Aseem Anand, Hans Lilja, Glenn Heller, Martin Fleisher, Howard I. Scher
Published 2009Artigo -
19
Distinct Patterns of Dysregulated Expression of Enzymes Involved in Androgen Synthesis and Metabolism in Metastatic Prostate Cancer Tumors by Nicholas Mitsiades, Clifford C. Sung, Nikolaus Schultz, Daniel C. Danila, Bin He, Vijay Kumar Eedunuri, Martin Fleisher, Chris Sander, Charles L. Sawyers, Howard I. Scher
Published 2012Artigo -
20
Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases by Aki Morikawa, Elisa de Stanchina, Elena Pentsova, Margaret Kemeny, Bob T. Li, Kendrick Tang, Sujata Patil, Martin Fleisher, Catherine Van Poznak, Larry Norton, Andrew D. Seidman
Published 2019Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Oncology
Biology
Prostate cancer
Metastasis
Circulating tumor cell
Pathology
Biochemistry
Cancer research
Gastroenterology
Gene
Urology
Chemotherapy
Prostate
Biomarker
Chemistry
Endocrinology
Breast cancer
Genetics
Hormone
Paleontology
Androgen deprivation therapy
Confidence interval
Adverse effect
Androgen receptor
Hazard ratio
Surgery
Cerebrospinal fluid